Wen Zhang

机构：Tianjin University of Commerce, Nanchang University, Chinese Academy of Medical Sciences & Peking Union Medical College, Soochow University, National Cancer Center, Second Affiliated Hospital of Nanchang University, Second Affiliated Hospital of Soochow University, Zhejiang University of Technology · ORCID：0000-0003-1939-4807

发表论文 84 篇 · 总被引 1651 次 · h-index 20

代表论文

• Innate Immunity, Inflammation, and Intervention in HBV Infection (2022 · Viruses · 被引 50)
• Phase 1 study of WNT pathway Porcupine inhibitor CGX1321 and phase 1b study of CGX1321 + pembrolizumab (pembro) in patients (pts) with advanced gastrointestinal (GI) tumors. (2023 · Journal of Clinical Oncology · 被引 26)
• Prevalence of myopia and associated risk factors among key schools in Xi’an, China (2022 · BMC Ophthalmology · 被引 26)
• CAPG interference induces apoptosis and ferroptosis in colorectal cancer cells through the P53 pathway (2023 · Molecular and Cellular Probes · 被引 17)
• Recent advances in colony stimulating factor-1 receptor (CSF1R) inhibitors (2025 · Biochemical Pharmacology · 被引 16)
• Targeting FLT3 for treating diseases: FLT3 inhibitors (2025 · Drug Discovery Today · 被引 13)